Recurrent allelic imbalance at the rat Pten locus in DMBA-induced fibrosarcomas

Asa Sjöling1, Emma Samuelson, Tatjana Adamovic

  • 1Department of Cell and Molecular Biology-Genetics, Lundberg Laboratory, Göteborg University, Sweden. Asa.Sjoling@microbio.gu.se

Insights

The tumor-suppressor gene Pten (phosphatase and tensin homolog) plays a role in rat fibrosarcomas. Loss of one Pten allele, not mutation, suggests haploinsufficiency contributes to cancer development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • The tumor-suppressor gene PTEN is frequently inactivated in human cancers.
  • The role of the homologous gene Pten in animal cancer models is less understood.
  • Investigating Pten's function in rat fibrosarcomas provides insights into cancer mechanisms.

Purpose of the Study:

  • To map the Pten gene in the rat genetic linkage map.
  • To investigate allelic imbalance of Pten in DMBA-induced rat fibrosarcomas.
  • To determine if Pten haploinsufficiency contributes to fibrosarcoma development.

Main Methods:

  • Sequencing of rat Pten introns to develop an intragenic PCR marker.
  • Genetic mapping using F2 progeny from BN and LE rat strains.
  • Analysis of allelic imbalance and DNA sequencing in induced fibrosarcomas.

Main Results:

  • Pten was localized to the distal part of rat chromosome 1 (RNO1).
  • Allelic imbalance near Pten was observed in over 60% of fibrosarcomas.
  • No mutations were detected in Pten exons 5-9, and normal mRNA was expressed.

Conclusions:

  • Pten haploinsufficiency is suggested as a significant factor in rat DMBA-induced fibrosarcomas.
  • The findings highlight the importance of Pten dosage in cancer development.
  • This study establishes a genetic marker for Pten in rats for future research.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...